Thuy Nguyen

Healthcare jobs bounce back after COVID-19, but some sectors still struggling

Research shows overall healthcare employment has fully recovered from pandemic lows by 2024; office-based behavioral health surges 84%

The United States healthcare workforce has bounced back from the massive job losses of early 2020, with employment now matching pre-pandemic projections, according to new research from the University of Michigan School of Public Health. But the recovery is far from even—while some healthcare settings are thriving, others continue to struggle with severe staffing shortages.

Lifesaving opioid addiction meds rarely started after emergency visits for overdose

Medications proven to effectively treat opioid addiction are rarely given after emergency department visits for overdose, and who gets them varies, sometimes greatly, depending on race, ethnicity or geography, University of Michigan researchers say.

Nursing homes hardest hit by health care employment declines

New research from Thuy Nguyen

Among health care job sectors, nursing homes have been the most adversely affected by declines in employment growth since the pandemic—a rate more than triple that of hospitals or physician offices, says a University of Michigan School of Public Health researcher.

Opioid limits didn't change surgery patients' experience, study shows

Worries that surgery patients would have a tougher recovery if their doctors had to abide by a five-day limit on opioid pain medication prescriptions didn’t play out as expected, a new study finds.

$3.3M grant to support U-M research surrounding surgical care for patients with opioid use disorder

The University of Michigan recently received a $3.3 million grant to launch a comprehensive data science project that aims to inform best practices on pre- and post-surgical care procedures for patients with opioid use disorder.

Minorities saw steeper drop in access to opioid use disorder meds during pandemic

New research from Thuy Nguyen

Relative to white patients, racial and ethnic groups saw a sharper decline in access to medicines to treat opioid use disorder during the early stages of the COVID-19 pandemic—intensifying pre-pandemic disparities, says a University of Michigan researcher.